Clinical Trials Browser

INDUSTRY × Neoplasms × tosedostat × Clear all

NCT00522938 2012-06-28

Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Phase 1/2 Terminated

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00780598 2012-06-28

OPAL

Phase 2 Completed

Other hematologic neoplasm

Hematologic Diseases, Neoplasms, Recurrence, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT00737555 2012-02-15

A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours

Phase 1 Completed

Neoplasms

NCT00689000 2010-10-22

Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)

Phase 1/2 Completed

MyeloidOther hematologic neoplasmPlasma cell

Leukemia, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms